Opsens (OPS:TSX) Annual Reports & Investor Relations Material

Overview

OpSens Inc. is a Canadian medical technology firm that specializes in physiological measurements for interventional cardiology. The company focuses on optical-based pressure guidewires to enhance the clinical outcomes of patients with coronary artery disease. Its flagship product, the OptoWire, is a second-generation guidewire that offers the lowest drift in the industry and provides excellent lesion access. The OptoWire has been used in over 90,000 patients across more than 30 countries and is approved for sale in the United States, European Union, Japan, and Canada. OpSens is committed to ongoing innovation and research to further advance the field of interventional cardiology.

Frequently Asked Questions

What is Opsens's ticker?

Opsens's ticker is OPS

What exchange is Opsens traded on?

The company's shares trade on the TSX stock exchange

Where are Opsens's headquarters?

They are based in Quebec City, Quebec

How many employees does Opsens have?

There are 51-200 employees working at Opsens

What is Opsens's website?

It is opsens.com

What type of sector is Opsens?

Opsens is in the Technology sector

What type of industry is Opsens?

Opsens is in the Scientific & Technical Instruments industry

Who are Opsens's peers and competitors?

The following five companies are Opsens's industry peers:

- Opsens

- Perceptron, Inc.

- Sensata Technologies

- Novanta

- OptiScan